Cholinergic Receptor, Nicotinic Alpha 9 (CHRNA9) Antibody

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
CHRNA9 Antibody is a Rabbit Polyclonal against CHRNA9.
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | Cholinergic Receptor, Nicotinic Alpha 9 (CHRNA9) |
Host | Rabbit |
Reactivity | Human |
Recommended Dilution | IHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Purification | Antigen Affinity Chromatography. |
Size 1 | 20 µl |
Size 2 | 50 µl |
Size 3 | 100 µl |
Size 4 | 200 µl |
Size 5 | 1 ml |
Form | Liquid |
Tested Applications | ELISA, IHC |
Buffer | PBS, pH 7.3, containing 0.02% sodium azide and 50% glycerol. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q9UGM1 |
Gene ID | 55584 |
OMIM | 605116 |
Background | Antibody anti-CHRNA9 |
Status | RUO |
Descripción
Related Products

CHRNA9 antibody
Ionotropic receptor with a probable role in the modulation of auditory stimuli. Agonist binding induces a conformation change that leads to the opening of an ion-conducting channel across the plasma membrane(PubMed:11752216, PubMed:25282151). The channel is permeable to a range of divalent cations including calcium, the influx of which may activate a potassium current which hyperpolarizes the cell membrane(PubMed:11752216, PubMed:25282151). In the ear, this may lead to a reduction in basilar membrane motion, altering the activity of auditory nerve fibers and reducing the range of dynamic hearing. This may protect against acoustic trauma. May also regulate keratinocyte adhesion(PubMed:11021840).
Ver Producto
Recombinant Human CHRNA9
Ver Producto
Cholinergic Receptor, Nicotinic Alpha 9 (CHRNA9) Antibody
Rabbit Polyclonal against the CHRNA9 protein.
Ver Producto